ORELLANA ET AL., SCI TRANS MED, 9:EAAM9327, 2017 Scientists demonstrate that a tumor-attacking miRNA joined with folate can precisely target cancer cells expressing folate receptors, suppress their gene expression, and slow them down.
See E.A. Orellana et al., “FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer,” Sci Trans Med, 9:eaam9327, 2017.
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?